Tags

Type your tag names separated by a space and hit enter

[Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
Med Klin. 1974 Mar 29; 69(13):541-5.MK

Authors

No affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

ger

PubMed ID

4831456

Citation

Schneider, E, et al. "[Effects of Additional Medication of Amantadine Sulfate in L-dopa-pretreated Patients With Parkinson's Syndrome (author's Transl)]." Medizinische Klinik, vol. 69, no. 13, 1974, pp. 541-5.
Schneider E, Fischer PA, Jacobi P. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Med Klin. 1974;69(13):541-5.
Schneider, E., Fischer, P. A., & Jacobi, P. (1974). [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. Medizinische Klinik, 69(13), 541-5.
Schneider E, Fischer PA, Jacobi P. [Effects of Additional Medication of Amantadine Sulfate in L-dopa-pretreated Patients With Parkinson's Syndrome (author's Transl)]. Med Klin. 1974 Mar 29;69(13):541-5. PubMed PMID: 4831456.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)]. AU - Schneider,E, AU - Fischer,P A, AU - Jacobi,P, PY - 1974/3/29/pubmed PY - 2000/3/22/medline PY - 1974/3/29/entrez SP - 541 EP - 5 JF - Medizinische Klinik JO - Med Klin VL - 69 IS - 13 SN - 0025-8458 UR - https://www.unboundmedicine.com/medline/citation/4831456/[Effects_of_additional_medication_of_Amantadine_sulfate_in_L_dopa_pretreated_patients_with_Parkinson's_syndrome__author's_transl_]_ L2 - https://medlineplus.gov/parkinsonsdisease.html DB - PRIME DP - Unbound Medicine ER -